Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Held

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
Circulation|September 9, 2021
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia SeverityHarmony R Reynolds, Leslee J Shaw, James K Min, et al.
The New England Journal of Medicine|November 10, 2025
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Xavier Rossello, Dan Atar, et al.
The Canadian Journal of Cardiology|October 21, 2015
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline CharacteristicsEva Lonn, Jackie Bosch, Janice Pogue, et al.
The New England Journal of Medicine|April 5, 2016
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseSalim Yusuf, Jackie Bosch, Gilles Dagenais, et al.
The New England Journal of Medicine|April 5, 2016
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular DiseaseSalim Yusuf, Eva Lonn, Prem Pais, et al.
Journal of the American Heart Association|February 27, 2024
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA TrialHarmony R Reynolds, Derek D Cyr, C Noel Bairey Merz, et al.
The New England Journal of Medicine|August 29, 2017
Bivalirudin versus Heparin Monotherapy in Myocardial InfarctionDavid Erlinge, Elmir Omerovic, Ole Fröbert, et al.
The New England Journal of Medicine|April 5, 2016
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseEva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
Journal of the American College of Cardiology|April 26, 2023
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA TrialDan D Nguyen, John A Spertus, Karen P Alexander, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Circulation|September 9, 2021
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia SeverityHarmony R Reynolds, Leslee J Shaw, James K Min, et al.
The New England Journal of Medicine|November 10, 2025
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Xavier Rossello, Dan Atar, et al.
The Canadian Journal of Cardiology|October 21, 2015
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline CharacteristicsEva Lonn, Jackie Bosch, Janice Pogue, et al.
The New England Journal of Medicine|April 5, 2016
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseSalim Yusuf, Jackie Bosch, Gilles Dagenais, et al.
The New England Journal of Medicine|April 5, 2016
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular DiseaseSalim Yusuf, Eva Lonn, Prem Pais, et al.
Journal of the American Heart Association|February 27, 2024
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA TrialHarmony R Reynolds, Derek D Cyr, C Noel Bairey Merz, et al.
The New England Journal of Medicine|August 29, 2017
Bivalirudin versus Heparin Monotherapy in Myocardial InfarctionDavid Erlinge, Elmir Omerovic, Ole Fröbert, et al.
The New England Journal of Medicine|April 5, 2016
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseEva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
Journal of the American College of Cardiology|April 26, 2023
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA TrialDan D Nguyen, John A Spertus, Karen P Alexander, et al.
Pageof 23